当前位置： SCI文献检索 > BLOOD期刊下所有文献 > Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.

Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.

Abstract：

:To directly determine whether the mechanism of activation of human plasminogen (HPg) by staphylokinase (Sak) required formation of an active complex of Sak and HPg, recombinant (r) variants of HPg were examined that allowed dissection of the steps involved in this activation. The rate of activation of wild-type (wt) r-HPg by equimolar levels of Sak was enhanced when small amounts of human plasmin (HPm) were included, suggesting that a Sak-HPm complex was a more effective plasminogen activator than a putative Sak-HPg complex. Incubation of equimolar Sak with a cleavage site resistant mutant of HPg (r-[R581 A]HPg) did not result in generation of amidolytic activity of the complex, in contrast to a similar experiment with streptokinase (SK) in place of Sak, where substantial amidolytic activity was generated. This result supplies evidence that an active complex of Sak and HPg does not form, as is the case with SK. Another mutant, r-[D646 E]HPg, which, upon activation, would lead to a form of HPm defective in enzymatic activity, is also not converted to its two-chain form by Sak, but is converted to the inactive two-chain form by urokinase, a direct plasminogen activator, and by equimolar complexes of SK or Sak with wtr-HPm. This shows that the active site of HPm is the functional plasminogen activator entity in the Sak-HPm complex. These results show that the mechanism of activation of HPg by Sak proceeds in a distinctly different manner than the similar activation by SK. Although SK does not require the presence of HPm for this activation, a necessary condition for the activation by Sak is formation of a small amount of HPm generated via another activation pathway. These different mechanisms have significant implications in production of the fibrinolytic state by these two indirect bacterial plasminogen activators.

journal_name

Blood

journal_title

Blood

authors

Grella DK,Castellino FJ

subject

Has Abstract

pub_date

1997-03-01 00:00:00

pages

1585-9

issue

5

eissn

0006-4971

issn

1528-0020

journal_volume

89

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

    abstract：:Sickle cell disease is a common hemolytic disorder with a broad range of complications, including vaso-occlusive episodes, acute chest syndrome (ACS), pain, and stroke. Heme oxygenase-1 (gene HMOX1; protein HO-1) is the inducible, rate-limiting enzyme in the catabolism of heme and might attenuate the severity of outco...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-06-361642

    authors： Bean CJ,Boulet SL,Ellingsen D,Pyle ME,Barron-Casella EA,Casella JF,Payne AB,Driggers J,Trau HA,Yang G,Jones K,Ofori-Acquah SF,Hooper WC,DeBaun MR

    更新日期：2012-11-01 00:00:00

  • p52Shc is required for CXCR4-dependent signaling and chemotaxis in T cells.

    abstract：:ShcA is an important mediator of Ras/MAPK activation in PTK-regulated pathways triggered by surface receptors. This function is subserved by the constitutively expressed p52-kDa isoform. Besides activating Ras, p52Shc couples the TCR to Rho GTPases, and thereby participates in actin cytoskeleton remodeling in T cells....

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2007-01-068411

    authors： Patrussi L,Ulivieri C,Lucherini OM,Paccani SR,Gamberucci A,Lanfrancone L,Pelicci PG,Baldari CT

    更新日期：2007-09-15 00:00:00

  • In vivo stem cell function of interleukin-3-induced blast cells.

    abstract：:The treatment of mice with high doses of 5-fluorouracil (5-FU) results in an enrichment of primitive hematopoietic progenitors. Using this procedure, we obtained a new class of murine hematopoietic colonies that had very high secondary plating efficiencies in vitro and could differentiate into not only myeloid cells b...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Tsunoda J,Okada S,Suda J,Nagayoshi K,Nakauchi H,Hatake K,Miura Y,Suda T

    更新日期：1991-07-15 00:00:00

  • Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the Randomized MRC Trial.

    abstract：:All-trans retinoic acid (ATRA) is an essential component of the treatment of acute promyelocytic leukemia (APL), but the optimal timing and duration remain to be determined. Molecular characterization of this disease can refine the diagnosis and could be potentially useful in monitoring response to treatment. Patients...

    journal_title：Blood

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：

    authors： Burnett AK,Grimwade D,Solomon E,Wheatley K,Goldstone AH

    更新日期：1999-06-15 00:00:00

  • c-myc is an erythropoietin early response gene in normal erythroid cells: evidence for a protein kinase C-mediated signal.

    abstract：:The proto-oncogene c-myc has been identified as an early response gene for erythropoietin (Epo) in transformed murine erythroleukemia cells. Epo activation of c-myc in these cells requires protein kinase C. We now show the fidelity of this signaling pathway in normal erythroid cells isolated from the spleens of phenyl...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Spangler R,Sytkowski AJ

    更新日期：1992-01-01 00:00:00

  • Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia.

    abstract：:Chronic myelomonocytic leukemia (CMML) is a myelodysplastic/myeloproliferative neoplasm with variable clinical course. To predict the clinical outcome, we previously developed a CMML-specific prognostic scoring system (CPSS) based on clinical parameters and cytogenetics. In this work, we tested the hypothesis that acc...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2016-05-714030

    authors： Elena C,Gallì A,Such E,Meggendorfer M,Germing U,Rizzo E,Cervera J,Molteni E,Fasan A,Schuler E,Ambaglio I,Lopez-Pavia M,Zibellini S,Kuendgen A,Travaglino E,Sancho-Tello R,Catricalà S,Vicente AI,Haferlach T,Haferlach

    更新日期：2016-09-08 00:00:00

  • Recombinant tumor necrosis factor enhances the locomotion of memory and naive B lymphocytes from human tonsils through the selective engagement of the type II receptor.

    abstract：:Recent studies performed in mice knocked out for the tumor necrosis factor (TNF ), the lymphotoxin-alpha, or the type I TNF receptor (R), genes have shown that these animals display gross defects in germinal center (GC) formation, suggesting that members of the TNF and TNFR superfamilies are involved in the control of...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Corcione A,Ottonello L,Tortolina G,Tasso P,Ghiotto F,Airoldi I,Taborelli G,Malavasi F,Dallegri F,Pistoia V

    更新日期：1997-12-01 00:00:00

  • Antithymocyte globulin with or without cyclosporin A: 11-year follow-up of a randomized trial comparing treatments of aplastic anemia.

    abstract：:Immunosuppression with antithymocyte globulin, (methyl)prednisolone, and cyclosporin A is considered the treatment of choice for the patient with aplastic anemia without a donor for standard-risk stem cell transplantation. This consensus is supported by the results of several series, including a randomized German tria...

    journal_title：Blood

    pub_type： 临床试验,杂志文章,随机对照试验

    doi：10.1182/blood-2002-04-1134

    authors： Frickhofen N,Heimpel H,Kaltwasser JP,Schrezenmeier H,German Aplastic Anemia Study Group.

    更新日期：2003-02-15 00:00:00

  • The supernatant of apoptotic cells causes transcriptional activation of hypoxia-inducible factor-1alpha in macrophages via sphingosine-1-phosphate and transforming growth factor-beta.

    abstract：:Macrophages infiltrating solid tumors exhibit a tumor-supporting phenotype and are critical for tumor development. Little is known which tumor-derived signal provokes this phenotype shift and how these signals are interpreted in macrophages to support tumor growth. We used the supernatant of apoptotic cells and notice...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2009-01-201889

    authors： Herr B,Zhou J,Werno C,Menrad H,Namgaladze D,Weigert A,Dehne N,Brüne B

    更新日期：2009-09-03 00:00:00

  • Clonal evolution and clinical correlates of somatic mutations in myeloproliferative neoplasms.

    abstract：:Myeloproliferative neoplasms (MPNs) are a group of clonal disorders characterized by aberrant hematopoietic proliferation and an increased tendency toward leukemic transformation. We used targeted next-generation sequencing (NGS) of 104 genes to detect somatic mutations in a cohort of 197 MPN patients and followed clo...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2013-11-537167

    authors： Lundberg P,Karow A,Nienhold R,Looser R,Hao-Shen H,Nissen I,Girsberger S,Lehmann T,Passweg J,Stern M,Beisel C,Kralovics R,Skoda RC

    更新日期：2014-04-03 00:00:00

  • Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implications.

    abstract：:Epigallocatechin-3-gallate (EGCG), a polyphenol extracted from green tea, is an antioxidant with chemopreventive and chemotherapeutic actions. Based on its ability to modulate growth factor-mediated cell proliferation, we evaluated its efficacy in multiple myeloma (MM). EGCG induced both dose- and time-dependent growt...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2006-05-022814

    authors： Shammas MA,Neri P,Koley H,Batchu RB,Bertheau RC,Munshi V,Prabhala R,Fulciniti M,Tai YT,Treon SP,Goyal RK,Anderson KC,Munshi NC

    更新日期：2006-10-15 00:00:00

  • Negative effects of GM-CSF signaling in a murine model of t(8;21)-induced leukemia.

    abstract：:The t(8;21)(q22;q22) is common in adult acute myeloid leukemia (AML). The RUNX1-ETO fusion protein that is expressed by this translocation is poorly leukemogenic and requires additional mutations for transformation. Loss of sex chromosome (LOS) is frequently observed in t(8;21) AML. In the present study, to evaluate w...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-04-350694

    authors： Matsuura S,Yan M,Lo MC,Ahn EY,Weng S,Dangoor D,Matin M,Higashi T,Feng GS,Zhang DE

    更新日期：2012-03-29 00:00:00

  • Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity.

    abstract：:Functional studies on native human dendritic cells (DCs) are hampered by technical difficulties in preparing fresh DCs. Recently, with the help of the monoclonal antibody M-DC8, we succeeded in isolating a major subpopulation of human blood DCs by a one-step immunomagnetic separation procedure. These cells strongly ex...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Schmitz M,Zhao S,Schäkel K,Bornhäuser M,Ockert D,Rieber EP

    更新日期：2002-08-15 00:00:00

  • Sodium salicylate activates caspases and induces apoptosis of myeloid leukemia cell lines.

    abstract：:Nonsteroidal antiinflammatory agents (NSAIA) have been shown to exert potent chemopreventive activity against colon, lung, and breast cancers. In this study, we show that at pharmacological concentrations (1 to 3 mmol/L) sodium salicylate (Na-Sal) can potently induce programmed cell death in several human myeloid leuk...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Klampfer L,Cammenga J,Wisniewski HG,Nimer SD

    更新日期：1999-04-01 00:00:00

  • Utilization of a continuous flow reactor to study the lipoprotein-associated coagulation inhibitor (LACI) that inhibits tissue factor.

    abstract：:A microperfusion system containing a glass capillary, the inner surface of which is coated with a phospholipid bilayer containing tissue factor, was used to explore the requirement for factors VIIa and Xa in the complex formed with the lipoprotein-associated coagulation inhibitor (LACI). Various combinations of factor...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Gemmell CH,Broze GJ Jr,Turitto VT,Nemerson Y

    更新日期：1990-12-01 00:00:00

  • CXCR4 is a key regulator of neutrophil release from the bone marrow under basal and stress granulopoiesis conditions.

    abstract：:The number of neutrophils in the blood is tightly regulated to ensure adequate protection against microbial pathogens while minimizing damage to host tissue. Neutrophil homeostasis in the blood is achieved through a balance of neutrophil production, release from the bone marrow, and clearance from the circulation. Acc...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2008-09-177287

    authors： Eash KJ,Means JM,White DW,Link DC

    更新日期：2009-05-07 00:00:00

  • Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.

    abstract：:The cellular immune defect in untreated Hodgkin's disease (HD) has long been recognized. This defect appears to be responsible for at least some of the morbidity and ultimately the mortality associated with the disease. In recent years, many studies have shown that the T cell component of the immune response is the ap...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Ford RJ,Tsao J,Kouttab NM,Sahasrabuddhe CG,Mehta SR

    更新日期：1984-08-01 00:00:00

  • Direct evidence for new T-cell generation by patients after either T-cell-depleted or unmodified allogeneic hematopoietic stem cell transplantations.

    abstract：:Successful allogeneic hematopoietic stem cell transplantation (HSCT) requires reconstitution of normal T-cell immunity. Recipient thymic activity, biologic features of the allograft, and preparative regimens all contribute to immune reconstitution. We evaluated circulating T-cell phenotypes and T-cell receptor rearran...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Lewin SR,Heller G,Zhang L,Rodrigues E,Skulsky E,van den Brink MR,Small TN,Kernan NA,O'Reilly RJ,Ho DD,Young JW

    更新日期：2002-09-15 00:00:00

  • Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma.

    abstract：:Proteasome inhibition is an effective treatment strategy for multiple myeloma. With improving survival, attention is increasingly focusing on ease of administration and toxicity profile. Ixazomib is an investigational, orally bioavailable 20S proteasome inhibitor. Sixty patients with relapsed and/or refractory multipl...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2014-01-548941

    authors： Kumar SK,Bensinger WI,Zimmerman TM,Reeder CB,Berenson JR,Berg D,Hui AM,Gupta N,Di Bacco A,Yu J,Shou Y,Niesvizky R

    更新日期：2014-08-14 00:00:00

  • Posttranscriptional deregulation of MYC via PTEN constitutes a major alternative pathway of MYC activation in T-cell acute lymphoblastic leukemia.

    abstract：:Cumulative evidence indicates that MYC, one of the major downstream effectors of NOTCH1, is a critical component of T-cell acute lymphoblastic leukemia (T-ALL) oncogenesis and a potential candidate for targeted therapy. However, MYC is a complex oncogene, involving both fine protein dosage and cell-context dependency,...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2011-02-336842

    authors： Bonnet M,Loosveld M,Montpellier B,Navarro JM,Quilichini B,Picard C,Di Cristofaro J,Bagnis C,Fossat C,Hernandez L,Mamessier E,Roulland S,Morgado E,Formisano-Tréziny C,Dik WA,Langerak AW,Prebet T,Vey N,Michel G,Gabert

    更新日期：2011-06-16 00:00:00

  • Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.

    abstract：:Human hematopoietic colony-forming cells (CFC) express the CD34 antigen (CD34+) as well as differentiation antigens such as CD33 and HLA-DR. CD34+ cells that do not express these latter differentiation antigens have been shown to contain few CFC in direct culture, but generate increasing numbers of CFC when cultured o...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Litzow MR,Brashem-Stein C,Andrews RG,Bernstein ID

    更新日期：1991-06-01 00:00:00

  • T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.

    abstract：:T-cell depletion of donor marrow decreases graft-versus-host disease resulting from transplants from unrelated and human leukocyte antigen (HLA)-mismatched related donors. However, there are diverse strategies for T-cell-depleted transplantation, and it is uncertain whether any improve leukemia-free survival (LFS). To...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Champlin RE,Passweg JR,Zhang MJ,Rowlings PA,Pelz CJ,Atkinson KA,Barrett AJ,Cahn JY,Drobyski WR,Gale RP,Goldman JM,Gratwohl A,Gordon-Smith EC,Henslee-Downey PJ,Herzig RH,Klein JP,Marmont AM,O'Reilly RJ,Ringdén O,Slav

    更新日期：2000-06-15 00:00:00

  • Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccination.

    abstract：:The recent success of chimeric antigen receptor (CAR)-T cell therapy for treatment of hematologic malignancies supports further development of treatments for both liquid and solid tumors. However, expansion of CAR-T cell therapy is limited by the availability of surface antigens specific for the tumor while sparing no...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2017-08-802926

    authors： Akahori Y,Wang L,Yoneyama M,Seo N,Okumura S,Miyahara Y,Amaishi Y,Okamoto S,Mineno J,Ikeda H,Maki T,Fujiwara H,Akatsuka Y,Kato T,Shiku H

    更新日期：2018-09-13 00:00:00

  • Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells.

    abstract：:Nitric oxide (NO), an important effector molecule involved in immune regulation and host defense, was shown to induce apoptosis in lymphoma cells. In the present report the NO donor glycerol trinitrate was found to induce apoptosis in Jurkat cells that are sensitive to CD95-mediated kill. In contrast, a CD95-resistant...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Chlichlia K,Peter ME,Rocha M,Scaffidi C,Bucur M,Krammer PH,Schirrmacher V,Umansky V

    更新日期：1998-06-01 00:00:00

  • Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: synergism with non-alloreactive (host x donor)F(1) T cells.

    abstract：:Induction of transplantation tolerance by means of bone marrow (BM) transplantation could become a reality if it was possible to achieve engraftment of hematopoietic stem cells under nonlethal preparatory cytoreduction of the recipient. To that end, BM facilitating cells, veto cells, or other tolerance-inducing cells,...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Bachar-Lustig E,Li HW,Gur H,Krauthgamer R,Marcus H,Reisner Y

    更新日期：1999-11-01 00:00:00

  • Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

    abstract：:The paradoxical correlation between thrombosis and the lupus anticoagulant (LAC) effect is an enigmatic feature of the antiphospholipid (aPL) syndrome. The Dutch authors previously reported that thrombosis-related anti-beta2-glycoprotein I (beta2GPI) antibodies recognize domain I and cause LAC. The American authors re...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2006-07-030148

    authors： de Laat B,Wu XX,van Lummel M,Derksen RH,de Groot PG,Rand JH

    更新日期：2007-02-15 00:00:00

  • Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels.

    abstract：:The t(11;14)(q13;q32) is the most common translocation in multiple myeloma (MM), resulting in up-regulation of cyclin D1. We used a segregation fluorescence in situ hybridization (FISH) assay to detect t(11;14) breakpoints in primary MM cases and real-time reverse transcriptase-polymerase chain reaction (RT-PCR) to qu...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2003-11-3837

    authors： Specht K,Haralambieva E,Bink K,Kremer M,Mandl-Weber S,Koch I,Tomer R,Hofler H,Schuuring E,Kluin PM,Fend F,Quintanilla-Martinez L

    更新日期：2004-08-15 00:00:00

  • B-cell depletion reactivates B lymphopoiesis in the BM and rejuvenates the B lineage in aging.

    abstract：:Aging is associated with a decline in B-lymphopoiesis in the bone marrow and accumulation of long-lived B cells in the periphery. These changes decrease the body's ability to mount protective antibody responses. We show here that age-related changes in the B lineage are mediated by the accumulating long-lived B cells....

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2010-09-307983

    authors： Keren Z,Naor S,Nussbaum S,Golan K,Itkin T,Sasaki Y,Schmidt-Supprian M,Lapidot T,Melamed D

    更新日期：2011-03-17 00:00:00

  • HbF reactivation in sibling BFU-E colonies: synergistic interaction of kit ligand with low-dose dexamethasone.

    abstract：:Mechanisms underlying fetal hemoglobin (HbF) reactivation in stress erythropoiesis have not been fully elucidated. We suggested that a key role is played by kit ligand (KL). Because glucocorticoids (GCs) mediate stress erythropoiesis, we explored their capacity to potentiate the stimulatory effect of KL on HbF reactiv...

    journal_title：Blood

    pub_type： 杂志文章

    doi：10.1182/blood-2002-05-1477

    authors： Gabbianelli M,Testa U,Massa A,Morsilli O,Saulle E,Sposi NM,Petrucci E,Mariani G,Peschle C

    更新日期：2003-04-01 00:00:00

  • Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells.

    abstract：:Leukemia inhibitory factor (LIF)/differentiation-inhibiting activity (DIA)/human interleukin for DA cells (HILDA) is a cytokine with biologic activities involving a variety of different types of target cells. Here we have tested LIF/DIA for possible effects on the growth and differentiation of normal human hematopoiet...

    journal_title：Blood

    pub_type： 杂志文章

    doi：

    authors： Leary AG,Wong GG,Clark SC,Smith AG,Ogawa M

    更新日期：1990-05-15 00:00:00